Phase I Clinical Trial of Adoptive Transfer of Autologous Folate Receptor alpha Redirected T Cells for Recurrent High Grade Serous Ovarian Fallopian Tube or Primary Peritoneal Cancer
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
Age: Between 0 - 99 Years
Gender: Male or Female
Recruitment StatusEnrolling By Invitation
If you need assistance finding a non-cancer study or if you have any questions, please email firstname.lastname@example.org